Insider · CIK 0001946739
Prashant Kohli
Files at GRCE (Acasti Pharma Inc.). First filing Sep 10, 2026, latest Sep 10, 2026.
In brief
Prashant Kohli files SEC Form 4 as CEO and director at GRCE (Acasti Pharma Inc.). Since Sep 10, 2026, Prashant Kohli has reported 1 open-market buy worth $214k and 0 open-market sells worth $0, the latest filed on Sep 10, 2026.
A track record needs three past buys with six months of prices behind them; Prashant Kohli has 0, so none is measured yet.
The newest scored trade: bought $214k of GRCE on Sep 9, 2026, filed Sep 10, 2026, scored 73 (notable). In the last 12 months: 1 buy worth $214k and 0 sells worth $0.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
GRCE: Acasti Pharma Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 73Notable | Acasti Pharma Inc. | $214k 100,000 shares | +468% | +3% from low-58% from high |
Transactions
Every row this insider has filed, 4 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 9, 2026 | GRCE Acasti Pharma Inc. | POpen-market purchase Common Stock | +100,000 | $2.14 | $214k | 121,357 | 33 d ago |
| Aug 28, 2026 | GRCE Acasti Pharma Inc. | AGrant or award Stock Option (Right to Buy)derivative | +267,160 | $0.00 | $0 | 267,160 | 42 d ago |
| Apr 14, 2025 | GRCE Acasti Pharma Inc. | AGrant or award Stock Option (Right to Buy)derivative | +225,400 | $0.00 | $0 | 225,400 | Apr 16, 2025 |
| Dec 19, 2023 | GRCE Acasti Pharma Inc. | AGrant or award Stock Options (Right to Buy)derivative | +41,668 | $0.00 | $0 | 41,668 | Dec 20, 2023 |
Questions about Prashant Kohli
Answered from the filings on this page, as of the latest one.
Is Prashant Kohli buying or selling?
In the last 12 months Prashant Kohli reported 1 open-market buy worth $214k and 0 open-market sells worth $0 on SEC Form 4; the latest was bought $214k of GRCE on Sep 9, 2026. Grants, option exercises and tax withholding are not counted.
How did Prashant Kohli's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Prashant Kohli has 0.
Where does Prashant Kohli file Form 4?
Prashant Kohli has filed Form 4 at GRCE (Acasti Pharma Inc.) as Chief Executive Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.